N-Methyl-Cyclazodone

Description

N-Methyl-Cyclazodone, Powder

N-Methyl-Cyclazodone is a derivative of Cyclazodone, a central nervous system stimulant initially developed in the 1960s. It is structurally similar to other compounds in the oxazolidinone class and has garnered attention for its potential to enhance cognitive function, focus, and physical stamina. As a stimulant, N-Methyl-Cyclazodone primarily influences the brain’s dopamine and norepinephrine systems, both of which are critical for motivation, alertness, and energy regulation.

N-Methyl-Cyclazodone (N-Cyclopropyl-N-Methyl-Pemoline) is an approximately 4x – 6x more potent derivative of Pemoline. According to patents filed by the inventors, N-Methyl-Cyclazo-done provided particularly strong central stimulant and motor excitant properties, such that a dose of 1 mg/kg in the mouse proved the compound to be equal in potency to d-amphetamine, but longer lasting in effect. The anorexigenic effect of the compound was also similar to that of d-amphetamine; however, unlike d-amphetamine, the compound was not a convulsant, had substantially lower toxicity, and had only a very slight cardiovascular effect in doses up to 5 mg/kg.

The addition of the methyl group to the structure of Cyclazo-done enhances the potency of the compound, potentially leading to stronger effects on cognitive and physical performance. N-Methyl-Cyclazodone is considered to be a potent dopamine reuptake inhibitor and norepinephrine reuptake inhibitor, both of which contribute to increased availability of these neurotransmitters in the brain, thus supporting improved cognitive and physical function.

Mechanism of Action:

N-Methyl-Cyclazodone primarily acts as a dopamine reuptake inhibitor (DRI) and norepinephrine reuptake inhibitor (NRI):

• Dopamine Reuptake Inhibition: By inhibiting the reuptake of dopamine, N-Methyl-Cyclazodone increases dopamine availability in the synaptic cleft. This enhances focus, motivation, and mental clarity, as dopamine is a critical neurotransmitter involved in reward, learning, and attention.
• Norepinephrine Reuptake Inhibition: The compound also increases levels of norepinephrine, which plays a role in alertness, energy regulation, and stress response. This action contributes to increased mental and physical stamina, as well as heightened alertness.

• Focus and Attention: N-Methyl-Cyclazodone is noted for its potential to enhance focus and attention by increasing the availability of dopamine in the brain.
• Increased Energy and Stamina: Through the modulation of norepinephrine, N-Methyl-Cyclazo-done may support physical energy and endurance.
• Cognitive Enhancement: Its effects on dopamine and norepinephrine systems suggest a possible role in improving cognitive performance, particularly in tasks requiring sustained focus and mental clarity.

Clinical Research:

• Stimulant Properties: Studies on Cyclazodone and its derivatives have demonstrated stimulant-like effects through modulation of the dopaminergic and noradrenergic systems. Research by Hays et al. (1965) indicated that Cyclazodone and its analogs enhance mental performance, alertness, and physical energy.
• Dopamine Modulation: Research on dopamine reuptake inhibitors suggests that compounds like N-Methyl-Cyclazodone could increase cognitive performance by enhancing the availability of dopamine, which is involved in attention and motivation.

Additional Effects:

• Motivation and Drive: N-Methyl-Cyclazo-done’s impact on the dopamine system may also contribute to increased motivation and drive, particularly in goal-oriented tasks.
• Heightened Alertness: Through norepinephrine modulation, the compound may support heightened levels of alertness, particularly in conditions requiring mental and physical stamina.

For a detailed lab analysis and comprehensive product specifications, please refer to the next sections.